Immunogenicity and Safety of TETRAXIM™ Given as a Booster Dose at 4 to 6 Years of Age
Clinical trial NCT01031303 · COMPLETED
Trial details
- NCT number
- NCT01031303
- Sponsor
- Sanofi
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2009-12-01
- Primary completion
- 2010-09-01
- Enrollment
- 123
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.